Inhibrx Biosciences, Inc. (INBX)
USD 11.69
(-2.58%)
USD 11.69
(-2.58%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 264.39 Million USD | 13.56% |
| 2022 | 232.81 Million USD | 137.41% |
| 2021 | 98.06 Million USD | 43.65% |
| 2020 | 68.26 Million USD | -43.14% |
| 2019 | 120.05 Million USD | 77.53% |
| 2018 | 67.62 Million USD | 70.49% |
| 2017 | 39.66 Million USD | 98.0% |
| 2016 | 20.03 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 39.05 Million USD | -85.9% |
| 2024 Q1 | 277 Million USD | 4.77% |
| 2023 Q2 | 237.98 Million USD | -0.25% |
| 2023 FY | 264.39 Million USD | 13.56% |
| 2023 Q1 | 238.58 Million USD | 2.48% |
| 2023 Q4 | 264.39 Million USD | 8.74% |
| 2023 Q3 | 243.13 Million USD | 2.17% |
| 2022 Q2 | 198.13 Million USD | 48.04% |
| 2022 FY | 232.81 Million USD | 137.41% |
| 2022 Q4 | 232.81 Million USD | 16.47% |
| 2022 Q3 | 199.9 Million USD | 0.89% |
| 2022 Q1 | 133.83 Million USD | 36.47% |
| 2021 Q1 | 63.91 Million USD | -6.38% |
| 2021 FY | 98.06 Million USD | 43.65% |
| 2021 Q2 | 97.56 Million USD | 52.66% |
| 2021 Q4 | 98.06 Million USD | -2.88% |
| 2021 Q3 | 100.97 Million USD | 3.49% |
| 2020 FY | 68.26 Million USD | -43.14% |
| 2020 Q4 | 68.26 Million USD | 31.73% |
| 2020 Q3 | 51.82 Million USD | 27.82% |
| 2020 Q2 | 40.54 Million USD | 0.0% |
| 2019 FY | 120.05 Million USD | 77.53% |
| 2019 Q4 | 120.05 Million USD | 0.0% |
| 2019 Q2 | 107.97 Million USD | 27.62% |
| 2019 Q1 | 84.6 Million USD | 0.0% |
| 2018 FY | 67.62 Million USD | 70.49% |
| 2017 FY | 39.66 Million USD | 98.0% |
| 2016 FY | 20.03 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 272.28 Million USD | 2.9% |
| Jaguar Health, Inc. | 45.86 Million USD | -476.44% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -599.222% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -2605.034% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 93.473% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -102.277% |
| ContextLogic Inc. | 206 Million USD | -28.345% |
| MiMedx Group, Inc. | 96.33 Million USD | -174.463% |
| MEI Pharma, Inc. | 8.35 Million USD | -3064.452% |
| AlloVir, Inc. | 45.01 Million USD | -487.338% |
| Novavax, Inc. | 2.57 Billion USD | 89.722% |
| Aptorum Group Limited | 5.25 Million USD | -4929.545% |
| Ardelyx, Inc. | 130.76 Million USD | -102.19% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 44.733% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -2084.193% |
| Vaxcyte, Inc. | 167.44 Million USD | -57.893% |
| Precigen, Inc. | 41.64 Million USD | -534.881% |
| Pharming Group N.V. | 244.07 Million USD | -8.324% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 45.666% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -2117.665% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -81.252% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -106.893% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -7392.164% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -3901.496% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -3901.496% |
| Bicycle Therapeutics plc | 224.41 Million USD | -17.815% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -220.733% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -3879.979% |
| Acelyrin, Inc. | 86.35 Million USD | -206.173% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -1738.723% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -2689.218% |
| Senti Biosciences, Inc. | 52.57 Million USD | -402.92% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -284.416% |
| AbCellera Biologics Inc. | 335.77 Million USD | 21.26% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -13416.871% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -103.049% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -16.558% |
| Chimerix, Inc. | 19.74 Million USD | -1239.023% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -2722.569% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -811.218% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -651.597% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -589.0% |
| Elevation Oncology, Inc. | 34.28 Million USD | -671.221% |
| Alkermes plc | 933.53 Million USD | 71.679% |
| Fortress Biotech, Inc. | 165.93 Million USD | -59.33% |
| Fortress Biotech, Inc. | 165.93 Million USD | -59.33% |
| Agenus Inc. | 462.29 Million USD | 42.809% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -269.88% |
| Dyadic International, Inc. | 2.34 Million USD | -11195.575% |
| ImmuCell Corporation | 18.81 Million USD | -1305.207% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -1525.715% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -836.69% |
| Lantern Pharma Inc. | 2.73 Million USD | -9550.39% |
| Immix Biopharma, Inc. | 3.72 Million USD | -7003.853% |
| Incyte Corporation | 1.59 Billion USD | 83.395% |
| IO Biotech, Inc. | 17.55 Million USD | -1405.981% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -633.235% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -7392.508% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -465.673% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -74.501% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -10713.497% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -861.034% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -12.404% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 46.535% |
| NextCure, Inc. | 14.99 Million USD | -1662.953% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -6441.069% |
| Onconetix, Inc. | 23.18 Million USD | -1040.552% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -3859.712% |
| Opthea Limited | 264.6 Million USD | 0.08% |
| PDS Biotechnology Corporation | 33.25 Million USD | -694.94% |
| PureTech Health plc | 125.58 Million USD | -110.53% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -450.56% |
| Seer, Inc. | 39.36 Million USD | -571.637% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -20249.573% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -429.521% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -19696.131% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -2854.078% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -16.243% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | 23.934% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -102.851% |
| ChromaDex Corporation | 26.5 Million USD | -897.397% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -2322.485% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -264.339% |
| CRISPR Therapeutics AG | 346.76 Million USD | 23.756% |
| Precision BioSciences, Inc. | 140.92 Million USD | -87.617% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -91.865% |
| Innoviva, Inc. | 568.55 Million USD | 53.498% |
| Summit Therapeutics Inc. | 125.25 Million USD | -111.078% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -327.58% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -871.022% |
| ESSA Pharma Inc. | 3.49 Million USD | -7464.653% |
| GlycoMimetics, Inc. | 6.9 Million USD | -3730.588% |
| GT Biopharma, Inc. | 6.63 Million USD | -3885.979% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -214.653% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -873.131% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -8096.175% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -258.412% |
| Aptose Biosciences Inc. | 15.8 Million USD | -1572.433% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -2294.905% |
| Soligenix, Inc. | 7.27 Million USD | -3534.275% |
| Century Therapeutics, Inc. | 175.94 Million USD | -50.272% |
| Kura Oncology, Inc. | 51.66 Million USD | -411.769% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -117.996% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -6297.048% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -3897.517% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -4.668% |
| Autolus Therapeutics plc | 263.9 Million USD | -0.183% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -2422.324% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -197.532% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -463.743% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | 25.071% |
| GRI Bio, Inc. | 2.69 Million USD | -9703.115% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -32557.473% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -750.375% |
| IGM Biosciences, Inc. | 220.17 Million USD | -20.081% |
| INmune Bio, Inc. | 18.86 Million USD | -1301.707% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -3.084% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -892.387% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -9625.92% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -7960.017% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -352.297% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -174.951% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | 0.13% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 67.876% |
| Verastem, Inc. | 71.18 Million USD | -271.413% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -437.64% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -585.339% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -440.321% |
| Histogen Inc. | 5.69 Million USD | -4540.864% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -5928.587% |
| Surrozen, Inc. | 8.14 Million USD | -3146.041% |
| Organovo Holdings, Inc. | 2.74 Million USD | -9521.179% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -84138.732% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -370.195% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -1501.199% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -417.367% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -31874.603% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -108.633% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -2344.979% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -75.222% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -10040.2% |
| Apollomics, Inc. | 14.15 Million USD | -1768.085% |
| Amarin Corporation plc | 279.58 Million USD | 5.436% |
| Mesoblast Limited | 188.79 Million USD | -40.039% |
| Turnstone Biologics Corp. | 14.14 Million USD | -1768.745% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -46.243% |
| Synaptogenix, Inc. | 5.52 Million USD | -4681.472% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -3876.986% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -55.425% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -2989.681% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -14944.444% |
| Exelixis, Inc. | 678.44 Million USD | 61.03% |
| Better Therapeutics, Inc. | 23.84 Million USD | -1008.925% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -61.168% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 55.506% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2375.515% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -16184.023% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -579.194% |
| Gritstone bio, Inc. | 125.91 Million USD | -109.968% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1701.513% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -5095.704% |
| Avid Bioservices, Inc. | 275.66 Million USD | 4.091% |
| Insmed Incorporated | 1.66 Billion USD | 84.09% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -3336.303% |
| MediWound Ltd. | 27.18 Million USD | -872.487% |
| OmniAb, Inc. | 87.4 Million USD | -202.506% |
| Alector, Inc. | 487.66 Million USD | 45.785% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 34.469% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -1334.953% |
| Zai Lab Limited | 240.17 Million USD | -10.081% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 58.037% |
| Aura Biosciences, Inc. | 29.22 Million USD | -804.609% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -178.08% |
| Immunic, Inc. | 25.36 Million USD | -942.219% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -281.868% |
| Veracyte, Inc. | 93.71 Million USD | -182.109% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -10004.052% |
| FibroGen, Inc. | 585.72 Million USD | 54.861% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1420.969% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -40383.803% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -4574.953% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 96.547% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -3125.055% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -214.668% |
| TG Therapeutics, Inc. | 169.08 Million USD | -56.365% |
| Galecto, Inc. | 5.89 Million USD | -4384.227% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -3091.574% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 89.903% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -817.32% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -1994.842% |
| XBiotech Inc. | 8.39 Million USD | -3048.625% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1701.513% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -397.161% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | 27.187% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -883.447% |
| Theravance Biopharma, Inc. | 169 Million USD | -56.44% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 78.25% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 47.167% |
| Vaxxinity, Inc. | 30.94 Million USD | -754.414% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 72.813% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -4283.772% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 64.523% |
| NexImmune, Inc. | 5.08 Million USD | -5100.195% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -71088.549% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -8498.474% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 96.28% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -5029.772% |
| Scopus BioPharma Inc. | 7.45 Million USD | -3446.748% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -905.515% |
| Ainos, Inc. | 7.39 Million USD | -3475.629% |
| Pluri Inc. | 34.11 Million USD | -675.064% |
| Prothena Corporation plc | 135.01 Million USD | -95.82% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -8.756% |
| Celularity Inc. | 102.92 Million USD | -156.866% |
| Rallybio Corporation | 9.43 Million USD | -2701.929% |
| Cue Biopharma, Inc. | 24.44 Million USD | -981.571% |
| MeiraGTx Holdings plc | 319.99 Million USD | 17.376% |
| Omeros Corporation | 403.25 Million USD | 34.436% |
| Humacyte, Inc. | 114.67 Million USD | -130.552% |
| Immunocore Holdings plc | 228.15 Million USD | -15.88% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -5323.385% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -244.527% |
| Blueprint Medicines Corporation | 918.64 Million USD | 71.219% |
| CalciMedica, Inc. | 4.02 Million USD | -6463.803% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -1414.955% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -71.523% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -208.086% |
| Sana Biotechnology, Inc. | 277.79 Million USD | 4.825% |
| Pulmatrix, Inc. | 15.96 Million USD | -1556.268% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -1576.219% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -974.494% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -5.415% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -420.596% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 78.161% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -731.86% |
| Nutriband Inc. | 1.07 Million USD | -24405.083% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -2386.504% |
| Vor Biopharma Inc. | 59.1 Million USD | -347.33% |
| Roivant Sciences Ltd. | 773.95 Million USD | 65.839% |
| Evogene Ltd. | 17.99 Million USD | -1369.65% |
| ProKidney Corp. | 29.21 Million USD | -804.949% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -267.315% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -37403.032% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 86.003% |
| CorMedix Inc. | 11.91 Million USD | -2118.497% |
| BioLineRx Ltd. | 50.7 Million USD | -421.459% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -76.898% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -198.945% |
| Atai Life Sciences N.V. | 49.16 Million USD | -437.793% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -748.701% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -1371.941% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -112.13% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -4576.158% |
| MediciNova, Inc. | 3.89 Million USD | -6693.946% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -1346.414% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -17476.306% |
| GeoVax Labs, Inc. | 3.51 Million USD | -7411.333% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | 33.446% |
| Biomea Fusion, Inc. | 30.69 Million USD | -761.486% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 90.286% |
| Mereo BioPharma Group plc | 15.96 Million USD | -1556.371% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -747.377% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -350.532% |
| Absci Corporation | 58.3 Million USD | -353.468% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1288.02% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -724.621% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -258.301% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -202.219% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -682.914% |
| Allakos Inc. | 74.79 Million USD | -253.496% |
| Imunon, Inc. | 8.53 Million USD | -2999.376% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -1075.014% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -130.281% |
| BioAtla, Inc. | 48.98 Million USD | -439.726% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2375.515% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -9413.854% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -102.436% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -1759.937% |
| XOMA Corporation | 145.58 Million USD | -81.611% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -685.356% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -284.517% |
| aTyr Pharma, Inc. | 31.59 Million USD | -736.757% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -327.656% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -487.991% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -446.238% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -9112.195% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -3140.861% |
| Akari Therapeutics, Plc | 4.58 Million USD | -5667.67% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1390.938% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 83.971% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -65357.976% |
| UroGen Pharma Ltd. | 243.52 Million USD | -8.569% |
| Sutro Biopharma, Inc. | 321.08 Million USD | 17.658% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -9473.943% |
| Orgenesis Inc. | 35.53 Million USD | -644.027% |
| Entera Bio Ltd. | 1.37 Million USD | -19072.589% |
| GH Research PLC | 6.7 Million USD | -3845.531% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -3788.088% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -1304.388% |
| Xencor, Inc. | 283.55 Million USD | 6.76% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -8755.284% |
| Replimune Group, Inc. | 113.21 Million USD | -133.531% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -6937.03% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -155.375% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -65357.976% |
| Portage Biotech Inc. | 4.45 Million USD | -5841.348% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -17476.306% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -1047.028% |
| OncoCyte Corporation | 49.29 Million USD | -436.31% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -6291.164% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -33053.016% |
| Purple Biotech Ltd. | 10 Million USD | -2542.579% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -4469.478% |
| scPharmaceuticals Inc. | 57.26 Million USD | -361.728% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -2034.239% |
| HilleVax, Inc. | 78.9 Million USD | -235.057% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -5135.446% |
| Tharimmune, Inc. | 1.81 Million USD | -14466.573% |
| Genprex, Inc. | 3.25 Million USD | -8024.557% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -874.925% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -4949.465% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -128244.66% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -73639.081% |
| OKYO Pharma Limited | 7.42 Million USD | -3462.801% |
| Savara Inc. | 37.19 Million USD | -610.879% |
| Curis, Inc. | 57.61 Million USD | -358.915% |
| Daré Bioscience, Inc. | 26.32 Million USD | -904.145% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -574.468% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -18209.557% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -1169.946% |
| BeiGene, Ltd. | 2.23 Billion USD | 88.164% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -1141.862% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -0.76% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -1142.785% |
| Erasca, Inc. | 78.61 Million USD | -236.327% |
| bluebird bio, Inc. | 424.62 Million USD | 37.736% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -40249.362% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 86.012% |
| DBV Technologies S.A. | 42.8 Million USD | -517.734% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -40249.362% |
| Moderna, Inc. | 4.57 Billion USD | 94.217% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -3679.7% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -15865.58% |
| Molecular Templates, Inc. | 31.17 Million USD | -748.192% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -1448.858% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 55.044% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -112.353% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -863.626% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -625.23% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -375.222% |
| MacroGenics, Inc. | 154.2 Million USD | -71.451% |
| RenovoRx, Inc. | 4.46 Million USD | -5820.063% |
| Adicet Bio, Inc. | 37.12 Million USD | -612.258% |
| Prime Medicine, Inc. | 60.78 Million USD | -334.995% |
| Aditxt, Inc. | 28.53 Million USD | -826.658% |
| Adagene Inc. | 45.16 Million USD | -485.331% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -146213.523% |
| Quantum-Si incorporated | 26.63 Million USD | -892.79% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 62.098% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -8590.07% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -129.982% |
| SciSparc Ltd. | 1.59 Million USD | -16476.176% |
| Vericel Corporation | 127.7 Million USD | -107.032% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -4651.034% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -209.742% |
| Generation Bio Co. | 171.63 Million USD | -54.046% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -2189.091% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -532.043% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -4.627% |
| Invivyd, Inc. | 51.71 Million USD | -411.264% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -187.452% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -3964.255% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -250.204% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -25795.201% |
| 2seventy bio, Inc. | 310.12 Million USD | 14.748% |
| ADMA Biologics, Inc. | 193.97 Million USD | -36.3% |
| Clene Inc. | 38.95 Million USD | -578.776% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -631.716% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -2.885% |
| GeoVax Labs, Inc. | 3.51 Million USD | -7411.333% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -38.96% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -2070.75% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -33.314% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -2068.055% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -449.542% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -400.35% |
| Vir Biotechnology, Inc. | 369.85 Million USD | 28.515% |
| Evaxion Biotech A/S | 17.61 Million USD | -1400.725% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -64.29% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -72.594% |
| Trevena, Inc. | 48.26 Million USD | -447.822% |
| Surrozen, Inc. | 8.14 Million USD | -3146.041% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -1124.311% |
| Cingulate Inc. | 10.36 Million USD | -2451.814% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -9514.182% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -608.972% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -7271.77% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -1910.57% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | 16.649% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -963.986% |
| Clearmind Medicine Inc. | 3.61 Million USD | -7223.806% |
| Kronos Bio, Inc. | 54.2 Million USD | -387.795% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -462.018% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1061.657% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -1217.274% |
| Statera Biopharma, Inc. | 22.67 Million USD | -1065.923% |
| ImmunityBio, Inc. | 1.09 Billion USD | 75.753% |
| Korro Bio, Inc. | 51.75 Million USD | -410.879% |
| Kineta, Inc. | 7.22 Million USD | -3560.897% |
| BioVie Inc. | 9.7 Million USD | -2625.072% |
| Codexis, Inc. | 49.94 Million USD | -429.352% |
| Celularity Inc. | 102.92 Million USD | -156.866% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -174.699% |
| Celcuity Inc. | 51.45 Million USD | -413.877% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -76491.714% |
| Cibus, Inc. | 206.11 Million USD | -28.272% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -522.46% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -903.797% |
| IN8bio, Inc. | 8.77 Million USD | -2914.022% |
| Kodiak Sciences Inc. | 213.59 Million USD | -23.783% |
| Annexon, Inc. | 47.11 Million USD | -461.123% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -195.273% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -174.343% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -1831.405% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 89.844% |
| Eyenovia, Inc. | 19.78 Million USD | -1236.634% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -49.3% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3342.13% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -997.099% |
| Arcellx, Inc. | 339.75 Million USD | 22.181% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -2122.138% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -7.677% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -2664.718% |
| Moolec Science SA | 13.94 Million USD | -1795.9% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -512.695% |
| Geron Corporation | 146.12 Million USD | -80.932% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -423.213% |
| Royalty Pharma plc | 6.29 Billion USD | 95.802% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -564.697% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -89704.556% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -10646.329% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -39.774% |
| Humacyte, Inc. | 114.67 Million USD | -130.552% |
| Structure Therapeutics Inc. | 29.05 Million USD | -810.089% |
| 89bio, Inc. | 59.96 Million USD | -340.922% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -899.093% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -22006.187% |
| Genelux Corporation | 8.42 Million USD | -3040.024% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -3756.33% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -93.949% |
| Notable Labs, Ltd. | 4.42 Million USD | -5872.216% |
| Liquidia Corporation | 73.13 Million USD | -261.495% |
| Mustang Bio, Inc. | 17.61 Million USD | -1400.596% |
| Immunovant, Inc. | 48.95 Million USD | -440.067% |
| Quantum-Si incorporated | 26.63 Million USD | -892.79% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -588.821% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -8420.464% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -257.956% |
| Acasti Pharma Inc. | 11.55 Million USD | -2187.704% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -1069.467% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -9625.92% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -616.951% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -19299.901% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -4237.106% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -964.586% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -1040.399% |
| PepGen Inc. | 34.63 Million USD | -663.449% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -2077.125% |
| United Therapeutics Corporation | 1.18 Billion USD | 77.636% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -3685.653% |
| Solid Biosciences Inc. | 38.45 Million USD | -587.477% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -2989.681% |
| Immuneering Corporation | 12 Million USD | -2101.717% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -84138.732% |
| Silo Pharma, Inc. | 1.56 Million USD | -16747.961% |
| Belite Bio, Inc | 4.21 Million USD | -6178.556% |
| XOMA Corporation | 145.58 Million USD | -81.611% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -10789.209% |
| Bionomics Limited | 10.15 Million USD | -2502.591% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -1130.236% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1053.886% |
| uniQure N.V. | 624.01 Million USD | 57.631% |
| Cassava Sciences, Inc. | 14.19 Million USD | -1762.557% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -146213.523% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -55.355% |
| Forte Biosciences, Inc. | 3.66 Million USD | -7111.948% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -101360.955% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -3818.631% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3342.13% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1420.969% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -2401.798% |
| Altimmune, Inc. | 16.54 Million USD | -1498.392% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 57.198% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1053.886% |
| Compugen Ltd. | 55.77 Million USD | -374.03% |
| Peak Bio, Inc. | 20.75 Million USD | -1173.962% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -139.347% |
| Benitec Biopharma Inc. | 4.96 Million USD | -5228.295% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -67.502% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -251.704% |
| Zura Bio Limited | 21.29 Million USD | -1141.734% |
| PolyPid Ltd. | 17.46 Million USD | -1413.568% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -135.225% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -251.704% |
| Instil Bio, Inc. | 99.8 Million USD | -164.917% |
| argenx SE | 444.95 Million USD | 40.58% |
| Immunome, Inc. | 28.65 Million USD | -822.57% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -3071.285% |
| Verona Pharma plc | 58.84 Million USD | -349.33% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -1726.781% |
| Shattuck Labs, Inc. | 14.85 Million USD | -1679.326% |
| CervoMed Inc. | 2.59 Million USD | -10085.507% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -5324.497% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -1975.927% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -2409.635% |
| Moolec Science SA | 13.94 Million USD | -1795.9% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -11181.824% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -375.562% |
| AnaptysBio, Inc. | 364.28 Million USD | 27.422% |
| Design Therapeutics, Inc. | 11.95 Million USD | -2111.358% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -1984.437% |
| NeurAxis, Inc. | 1.91 Million USD | -13722.586% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -579.177% |
| Lumos Pharma, Inc. | 13.33 Million USD | -1882.975% |
| Achilles Therapeutics plc | 19.08 Million USD | -1285.184% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -1726.781% |
| 180 Life Sciences Corp. | 5.38 Million USD | -4807.736% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1020.867% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1061.657% |
| Nutriband Inc. | 1.07 Million USD | -24405.083% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -764.076% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -1721.997% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | 34.112% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -714.184% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -1926.117% |
| Palisade Bio, Inc. | 2.73 Million USD | -9552.793% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -4933.124% |
| Beam Therapeutics Inc. | 478.38 Million USD | 44.733% |
| Neurogene Inc. | 36.54 Million USD | -623.385% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | 33.562% |
| AEON Biopharma, Inc. | 159.88 Million USD | -65.358% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -454.858% |
| Sesen Bio, Inc. | 30.98 Million USD | -753.311% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -918.412% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -3377.802% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -35.073% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -37.662% |
| Athira Pharma, Inc. | 30.05 Million USD | -779.629% |
| Vaccinex, Inc. | 5.94 Million USD | -4349.512% |
| HCW Biologics Inc. | 15.05 Million USD | -1656.517% |
| XOMA Corporation | 145.58 Million USD | -81.611% |
| Nektar Therapeutics | 267.04 Million USD | 0.995% |
| Arvinas, Inc. | 644.6 Million USD | 58.984% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1390.938% |
| Merus N.V. | 102.15 Million USD | -158.823% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -80.656% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -177.954% |
| Rezolute, Inc. | 11.73 Million USD | -2153.196% |
| Clene Inc. | 38.95 Million USD | -578.776% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -9185.378% |
| BeyondSpring Inc. | 48.26 Million USD | -447.743% |
| Synlogic, Inc. | 32.89 Million USD | -703.739% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -1709.279% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -16080.539% |
| Peak Bio, Inc. | 20.75 Million USD | -1173.962% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -316.631% |
| Krystal Biotech, Inc. | 39.71 Million USD | -565.735% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | 29.804% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -165.534% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -60998.709% |
| MannKind Corporation | 721.36 Million USD | 63.349% |
| Ikena Oncology, Inc. | 22.33 Million USD | -1083.747% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -12574.497% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -157.715% |
| Gossamer Bio, Inc. | 249.14 Million USD | -6.118% |
| CohBar, Inc. | 1.03 Million USD | -25478.587% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -2373.477% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1288.02% |
| Legend Biotech Corporation | 589.93 Million USD | 55.183% |
| Mural Oncology plc | 37.92 Million USD | -597.084% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -99.335% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -11418.595% |
| Disc Medicine, Inc. | 22.87 Million USD | -1055.803% |
| Champions Oncology, Inc. | 28.03 Million USD | -843.071% |
| REGENXBIO Inc. | 262.22 Million USD | -0.824% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -7770.268% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -2009.382% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -1868.414% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -1146.829% |
| Vaxart, Inc. | 34.02 Million USD | -677.046% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -1196.712% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -826.648% |
| Cellectis S.A. | 249.57 Million USD | -5.936% |
| Longeveron Inc. | 5.33 Million USD | -4853.907% |
| Repare Therapeutics Inc. | 41.81 Million USD | -532.225% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 89.008% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -337.964% |
| Revolution Medicines, Inc. | 262.39 Million USD | -0.76% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -12448.173% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -2965.036% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -2140.403% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -1782.717% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -12191.492% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 94.866% |
| Denali Therapeutics Inc. | 122.96 Million USD | -115.016% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -4651.034% |
| Veru Inc. | 32.81 Million USD | -705.755% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -3749.032% |
| Cingulate Inc. | 10.36 Million USD | -2451.814% |
| Passage Bio, Inc. | 39.26 Million USD | -573.399% |
| Context Therapeutics Inc. | 4.19 Million USD | -6207.442% |
| Exicure, Inc. | 8.54 Million USD | -2992.642% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -795.994% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -2421.362% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -1099.537% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -62.216% |
| Nuvalent, Inc. | 31.82 Million USD | -730.814% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -4056.012% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -319.52% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -1368.833% |
| OmniAb, Inc. | 87.4 Million USD | -202.506% |
| Anew Medical, Inc. | 8.24 Million USD | -3107.916% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -590.51% |
| Lipocine Inc. | 2.63 Million USD | -9946.629% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -906.357% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -557.49% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -892.387% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -206.881% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -4795.205% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -219.516% |
| Ocugen, Inc. | 23.98 Million USD | -1002.406% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -469.72% |
| Q32 Bio Inc. | 233.12 Million USD | -13.41% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -2816.281% |
| Alumis Inc. Common Stock | 53.5 Million USD | -394.168% |
| Equillium, Inc. | 27.95 Million USD | -845.702% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -27.977% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -4598.876% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -4210.963% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -68.052% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -280.784% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -2550.739% |
| Dominari Holdings Inc. | 4.63 Million USD | -5604.207% |
| Edesa Biotech, Inc. | 1.84 Million USD | -14256.249% |
| vTv Therapeutics Inc. | 29.56 Million USD | -794.206% |
| Bio-Techne Corporation | 744.34 Million USD | 64.48% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -109.669% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | 23.244% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -551.608% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -813.043% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -186.26% |
| Nkarta, Inc. | 105.6 Million USD | -150.369% |
| BioCardia, Inc. | 4.59 Million USD | -5660.131% |
| Iterum Therapeutics plc | 32.66 Million USD | -709.473% |